KindlyMD (NASDAQ:NAKA) Price Target Lowered to $0.50 at B. Riley Financial

KindlyMD (NASDAQ:NAKA) had its target price lowered by research analysts at B. Riley Financial from $1.00 to $0.50 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. B. Riley Financial’s price target would suggest a potential upside of 114.87% from the company’s current price.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of KindlyMD in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $4.25.

KindlyMD Stock Performance

NASDAQ NAKA traded down $0.01 during trading hours on Monday, hitting $0.23. 2,973,248 shares of the company’s stock were exchanged, compared to its average volume of 5,735,379. The business’s 50 day moving average is $0.37 and its 200-day moving average is $2.05. KindlyMD has a 12-month low of $0.23 and a 12-month high of $34.77. The firm has a market capitalization of $102.35 million, a P/E ratio of -0.21 and a beta of 31.48.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of NAKA. Rathbones Group PLC acquired a new stake in KindlyMD during the second quarter valued at approximately $1,523,000. Geode Capital Management LLC raised its position in shares of KindlyMD by 76.2% during the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock valued at $484,000 after acquiring an additional 8,386 shares in the last quarter. Osaic Holdings Inc. bought a new position in KindlyMD during the second quarter worth $215,000. Vontobel Holding Ltd. acquired a new position in KindlyMD in the third quarter worth $335,000. Finally, Almanack Investment Partners LLC. acquired a new position in KindlyMD in the third quarter worth $1,377,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.